Halozyme Therapeutics Inc. (HALO)

Halozyme Therapeutics Inc. (HALO $73.97)
- $73.97 P/E (TTM): 17.75X Cap: $8.84B
- View HALO Profile
- View Questions on HALO

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Halozyme Therapeutics Inc. (HALO $73.97)
- $73.97 P/E (TTM): 17.75X Cap: $8.84B
- View HALO Profile
- View Questions on HALO

Q: There has been some recent news indicating a positive outlook for Halozyme Therapeutics future earnings. Please provide 5i's perspective.
Thank you, Patrick

Read Answer Asked by Patrick on February 03, 2022